Adaptation and Validation of the Instrument Treatment Outcomes Profile to the Chilean Population

Castillo‐Carniglia, Álvaro; Marín, José D.; Soto-Brandt, Gonzalo; Donoso, María Paz; Piñol, Diego; Martín, Juan San; Huepe, David; Alvarado, Rubén; Eastwood, Brian J.; Huidobro, Rodrigo Portilla

doi:10.1016/j.jsat.2015.03.002

Cited by 8 publications

(4 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is of particular importance, given the high proportion of patients attending AoD services with alcohol as their PDOC. The validation of the ATOP adds to the number of studies that have examined versions of the TOP—including British [1], Chilean [43], Chinese [44] and, more recently, Greek [45] adaptations. Together, these studies validate the TOP and its variants across four languages and different national settings, highlighting the robustness of the TOP scales.…”

Section: Discussionmentioning

confidence: 99%

Assessing the concurrent validity, inter‐rater reliability and test–re‐test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations

et al. 2021

View full text Add to dashboard Cite

Background and Aims The Australian Treatment Outcomes Profile (ATOP) is a brief instrument measuring recent substance use, risk profile and general health and wellbeing among clients attending alcohol and other drug (AoD) treatment services. This study evaluates the ATOP for concurrent validity, inter‐rater and test–re‐test reliability among alcohol and opioid treatment groups. Design For concurrent validity and inter‐rater reliability, participants completed an ATOP with a clinician and an ATOP plus standardized questionnaires (time‐line follow‐back, Opiate Treatment Index, Kessler‐10, 12‐item Short Form Survey, World Health Organization Quality of Life‐BREF, Personal Wellbeing Index) with a researcher within 3 days. For test–re‐test reliability, participants completed two ATOPs with a researcher within a 3‐day interval. Setting Outpatient AoD treatment centres in Australia. Participants For testing concurrent validity and inter‐rater reliability, 278 participants were recruited by advertisements in waiting‐rooms or clinician invitation during 2016 to 2018. A further 94 participants were recruited to examine test–re‐test reliability. Measurements Statistical tests used for concurrent validity and test–re‐test reliability were Pearson’s and Spearman’s rank order correlations for continuous variables, and Cohen’s κ for nominal variables. Inter‐rater reliability was assessed using Krippendorf’s α. Findings Most Australian Treatment Outcomes Profile items returned excellent or moderate validity and reliability. For the main substances used—alcohol, cannabis and benzodiazepines—concurrent validity, inter‐rater reliability and test–re‐test reliability all reached excellent or good agreement (0.72–0.96). Psychological health, physical health and quality of life showed fair to strong agreement with their comparator scales (0.47–0.85). Conclusions The Australian Treatment Outcomes Profile is a validated and reliable instrument for assessing recent substance use and clinical risk, health and welfare among alcohol and opioid clients in alcohol and other drug treatment settings. Its ability to reliably measure complex constructs, such as psychological and physical health, against longer scales makes it suitable for integration into routine clinical care, enabling regular monitoring of patient outcomes and safety parameters.

show abstract

Section: Discussionmentioning

confidence: 99%

Assessing the concurrent validity, inter‐rater reliability and test–re‐test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The idea of a clinically useful AoD outcomes measure has proven appealing to health services around the world. As well as the ATOP there are Chilean and Chinese versions of the TOP currently in use, with Hellenic and youth versions reportedly under development. Although there are minor differences across scales, the Substance Use, Psychological Health, Physical Health and Quality of Life items are extremely similar.…”

Section: Discussionmentioning

confidence: 99%

Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence

Mills

Lintzeris

Bruno

et al. 2020

Drug and Alcohol Review

View full text Add to dashboard Cite

Introduction and Aims. The Australian Treatment Outcomes Profile (ATOP) was developed as a clinical tool for monitoring the substance use, health and wellbeing of clients in alcohol and other drug treatment. This is the first psychometric validation of the ATOP in a cannabis-dependent treatment population. Design and Methods. A total of 128 individuals with cannabis dependence enrolled in an outpatient randomised controlled trial were administered the ATOP and gold-standard health and wellbeing questionnaires once by clinicians and once by researchers at baseline. Concurrent validity was assessed by testing ATOP Psychological Health, Physical Health and Quality of Life questions against concurrently administered goldstandard questionnaires: the Short Form 36 Health Survey (SF-36), the 21-item Depression, Anxiety and Stress Scale (DASS-21) and the Sheehan Disability Scale (SDS). Interrater reliability was tested by comparing clinician-administered ATOP items at the medical screening interview to the same ATOP items administered by researchers at baseline. Results. ATOP Psychological Health showed moderate to strong correlations with SF-36 Mental Components, SF-36 Mental Health and DASS-21 scores (r = 0.40-0.52) and ATOP Physical Health with SF-36 Physical Components and SF-36 General Health scores (r = 0.36-0.67). The ATOP Quality of Life scale showed moderate agreement with the SDS and sixdimensional health state short form scales (r = 0.38-0.40). ATOP substance use, employment, education and child care items showed good to excellent interrater reliability (Krippendorff's α = 0.62-0.81), and tobacco use, Psychological Health, Physical Health and Quality of Life showed fair to moderate interrater reliability (Krippendorff's α = 0.42-0.53). Discussion and Conclusions. The ATOP appears to be valid and reliable when tested in a population with cannabis-dependence, justifying its widespread use in clinical settings. [Mills L, Lintzeris N, Bruno R, Montebello M, Dunlop A, Deacon RM, Copeland J, Jefferies M, Rivas C, Mammen K. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug Alcohol Rev 2020;39:356-364]

show abstract

“…In the Australian Alcohol and Other Drug (AOD) treatment sector the Australian Treatment Outcomes Profile (ATOP) is a brief clinical outcomes tool widely used to monitor clients' substance use, health wellbeing and clinical risk factors [2][3][4][5]. It builds upon the Treatment Outcomes Profile (TOP) used in Britain [6] and similar scales developed internationally [7][8][9]. The ATOP has demonstrated reliability and validity across different populations [10][11][12][13],…”

Section: Introductionmentioning

confidence: 99%

Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile

et al. 2023

View full text Add to dashboard Cite

AimsThe Austraian Treatment Outcomes Profile (ATOP) is a brief clinical outcomes tool used widely in the Australian alcohol and other drugs treatment sector to monitor clients’ substance use, health, wellbeing and clinical risk factors. It has demonstrated reliability and validity, and has recommended clinical cut‐offs for assessing single‐occasion client‐rated health scores. This study determined clinically meaningful change thresholds for ATOP substance use and health and wellbeing variables for use by clinicians in monitoring client progress, and for quality improvement and service evaluation.Design, Setting and ParticipantsA framework for assessing clinically meaningful changes scores was developed by (1) calculating statistically reliable change thresholds using data‐driven techniques with a reference sample of clinical ATOP data and (2) conducting a multi‐disciplinary subject matter expert group to review the utility and validity of data‐derived clinically meaningful change. The study was conducted within Outpatient Alcohol and Other Drug treatment services in New South Wales, Australia. The reference sample comprised 6100 ATOPs from clients at entry to public outpatient Alcohol and Other Drug treatment services; the subject matter expert group comprised 29 key stakeholders from the specialist alcohol and other drug treatment sector.Measurements and FindingsWe used the Reliable Change Index method to calculate clinically meaningful change thresholds for ATOP variables. For substance use variables, a change of 30% in days of use in the last 28 (minimum 4 days) was the threshold for clinically meaningful change for substance use; for health and wellbeing variables, a change of 2 or more points in psychological health, physical health or quality of life scores (measured on 0–10 scales) was the minimum clinically meaningful change.ConclusionsClinically meaningful change thresholds have been proposed for Australian Treatment Outcomes Profile substance use and health and wellbeing items, based on statistical reliability and subject matter expert assessment. These will be used in the development of an outcomes metric for assessing change and assigning meaning in aggregated data for evaluation of services.

show abstract

Adaptation and Validation of the Instrument Treatment Outcomes Profile to the Chilean Population

Cited by 8 publications

References 21 publications

Assessing the concurrent validity, inter‐rater reliability and test–re‐test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations

Assessing the concurrent validity, inter‐rater reliability and test–re‐test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations

Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence

Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile

Contact Info

Product

Resources

About